Allison Perry

Markey Researchers Develop Web-Based App to Predict Glioma Mutations

Published: Aug 19, 2014

LEXINGTON, Ky. (Aug. 19, 2014) – A new web-based program developed by University of Kentucky Markey Cancer Center researchers will provide a simple, free way for healthcare providers to determine which brain tumor cases require testing for a genetic mutation.

 

Gliomas – a type of tumor that begins in the brain or spine – are the most common and deadly form of brain cancer in adults, making up about 80 percent of malignant brain cancer cases. In some of these cases, patients have a mutation in a specific gene, known as an IDH1 mutation – and patients who have this tend to survive years longer than those who do not carry the mutation.

 

Developed by UK researchers Li Chen, Eric Durbin, and Craig Horbinski in collaboration with software architect Isaac Hands of the UK Markey Cancer Center Cancer Research Informatics Shared Research Facility, the program uses a statistical model to accurately predict the likelihood that a patient carries the IDH1 mutation and requires screening.

 

Gliomas are often tested for IDH1 mutation following surgery to remove the tumor, but undergoing this type of testing often requires stringent insurance pre-approvals due to rising healthcare costs, Horbinski says.

 

"Currently, there are no universally accepted guidelines for when gliomas should be tested for this mutation," Horbinski said. "Obtaining insurance pre-approval for additional molecular testing is becoming more commonplace, and this program will assist healthcare providers with an evidence-based rationale for when IDH1 screening is necessary."

 

Additionally, Horbinski notes that the program will help conserve research dollars by helping brain cancer researchers narrow down which specific older gliomas in tumor banks – previously removed in a time before IDH1 testing was routine – should be tested as data for research projects.

 

Horbinski's research on the program was published in the May issue of Neuro-Oncology. The work was funded through a grant from the National Cancer Institute, the Peter and Carmen Lucia Buck Training Program in Translational Clinical Oncology, and the University of Kentucky College of Medicine Physician Scientist Program.

 

MEDIA CONTACT: Allison Perry, (859) 323-2399 or allison.perry@uky.edu

screen_shot_2014-08-18_at_4.41.45_pm.png
August
 
 
 
 
 
 
1
 
Sat
2
 
Sun
3
 
Mon
4
 
Tue
5
 
Wed
6
 
Thu
7
Curator Tour
Fri
8
 
Sat
9
 
Sun
10
 
Mon
11
 
Tue
12
 
Wed
13
 
Thu
14
 
Fri
15
 
Sat
16
 
Sun
17
 
Mon
18
We Are UK
Tue
19
 
Wed
20
 
Thu
21
Parent and Families Reception
Fri
22
K Team Meeting: K Week Overview
Big Blue U
Campus Ruckus
Getting Around Campus and Beyond
Sat
23
The Late Night Film Series Presents - Fast and Furious 7
K Team Meeting: Lunch and Campus Tour
UK Lex-Mart
Pedalpalooza
Bowman's Bash
Sun
24
Bowman's Bash
K Team Meeting: Dinner with Your K Team
Kentucky at Kroger
Mon
25
K Team Meeting: Common Reading Experience Discussion
Bicycle-Friendly Lexington
Tue
26
First Day of Classes
Don't Steal Bikes, Bro
Understanding Lexington's Bicycle Facilities
First Day of Classes
Wildcat Wellness Meditation
Wed
27
The Late Night Film Series Presents - The Wind Rises
The Late Night Film Series Presents - Avengers: Age of Ultron
Adjusting to College
Wildcat Wellness - Yoga for Relaxation
Painting and Mocktails
Terrace Time Out at the Hilary J. Boone Center
Thu
28
The Late Night Film Series Presents - Divergent
The Late Night Film Series Presents - Ex Machina
Wildcat Block Watch
Chapel Talk: Faith and Science in an Evolving World
Royalty Showcase
Fri
29
 
Sat
30
 
Sun
31
Wildcat Wellness Expressions - Inspiration Object
UK Mock Trial Informational Meeting
Mon
 
 
 
 
 
Reset Page